The purpose of the study is to determine how safe and effective this study medication is when administered orally by tablet once daily for 84 days (12 weeks). We will also be evaluating the safety and effectiveness of the study medication when taken with empagliflozin (Jardience) in some participants. Jardience is an FDA approved drug used to improve glycemic control in adults with type 2 diabetes.
The study medication is being evaluated for a possible treatment for Non-alcoholic steatohepatitis (NASH). NASH is a key cause of chronic liver disease and liver-related medical conditions. Many are not aware that they have NASH although diagnosis can be done through laboratory testing and procedures.
You may qualify if:
- You are 18-75 years old
- You have been diagnosed with type 2 diabetes